Back
Collegium Pharmaceutical Vs. Supernus Pharmaceuticals Industry Stock Comparison
Buy
53
COLL
Collegium Pharmaceutical
Last Price:
38.05
Seasonality Move:
-1.07%
Sell
43
SUPN
Supernus Pharmaceuticals
Last Price:
31.32
Seasonality Move:
12.84%
Buy
53
Collegium Pharmaceutical (COLL)
is a Buy
Is Collegium Pharmaceutical a Buy, Sell or Hold?
- The current Collegium Pharmaceutical [COLL] share price is $37.33. The Score for COLL is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- COLL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Supernus Pharmaceuticals (SUPN)
is a Sell
Is Supernus Pharmaceuticals a Buy, Sell or Hold?
- The current Supernus Pharmaceuticals [SUPN] share price is $31.16. The Score for SUPN is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- SUPN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
COLL Stock Price Chart
What is Collegium Pharmaceutical's stock price today?
-
The Collegium Pharmaceutical share price today is $37.33
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and COLL is experiencing slight buying pressure.
SUPN Stock Price Chart
What is Supernus Pharmaceuticals's stock price today?
-
The Supernus Pharmaceuticals share price today is $31.16
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SUPN is experiencing buying pressure, which is a positive indicator for future bullish movement.
COLL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 53.36 | Buy |
| Chaikin Money Flow: | 3552 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.31 - 38.45) | Buy |
| Bollinger Bands (100): | (31.89 - 37.99) | Buy |
SUPN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.28 | Sell |
| Relative Strength Index (14 RSI): | 53.01 | Buy |
| Chaikin Money Flow: | 262452 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.36 - 32.04) | Buy |
| Bollinger Bands (100): | (27.68 - 32.14) | Buy |
COLL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.15 | Buy |
| 20-day SMA: | 36.25 | Buy |
| 50-day SMA: | 37.54 | Sell |
| 200-day SMA: | 29.23 | Buy |
| 8-day EMA: | 37.04 | Buy |
| 20-day EMA: | 36.89 | Buy |
| 50-day EMA: | 36.5 | Buy |
| 200-day EMA: | 31.06 | Buy |
SUPN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.44 | Buy |
| 20-day SMA: | 30.18 | Buy |
| 50-day SMA: | 31.68 | Sell |
| 200-day SMA: | 29.09 | Buy |
| 8-day EMA: | 30.5 | Buy |
| 20-day EMA: | 30.61 | Buy |
| 50-day EMA: | 30.76 | Buy |
| 200-day EMA: | 30.23 | Buy |
Collegium Pharmaceutical Earnings Growth & COLL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.05 per share, an increase this year of $0.80 per share, and an increase next year of $0.64 per share.
Supernus Pharmaceuticals Earnings Growth & SUPN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.34 per share, an increase next quarter of $0.07 per share, a decrease this year of $0.35 per share, and an increase next year of $0.31 per share.
Collegium Pharmaceutical Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Supernus Pharmaceuticals Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||